Management of atrial fibrillation in COVID-19 pandemic

Yu Feng Hu, Wen Han Cheng, Yuan Hung, Wen Yu Lin, Tze Fan Chao, Jo Nan Liao, Yenn Jiang Lin, Wei Shiang Lin, Yi Jen Chen, Shih Ann Chen*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations


The health crisis due to coronavirus disease 2019 (COVID-19) has shocked the world, with more than 1 million infections and casualties. COVID-19 can present from mild illness to multi-organ involvement, but especially acute respiratory distress syndrome. Cardiac injury and arrhythmias, including atrial fibrillation (AF), are not uncommon in COVID-19. COVID-19 is highly contagious, and therapy against the virus remains premature and largely unknown, which makes the management of AF patients during the pandemic particularly challenging. We describe a possible pathophysiological link between COVID-19 and AF, and therapeutic considerations for AF patients during this pandemic.

Original languageEnglish
Pages (from-to)1679-1685
Number of pages7
JournalCirculation Journal
Issue number10
StatePublished - 25 Sep 2020


  • Ablation
  • Antiarrhythmic drugs
  • Atrial fibrillation
  • Oral anticoagulation


Dive into the research topics of 'Management of atrial fibrillation in COVID-19 pandemic'. Together they form a unique fingerprint.

Cite this